22 May 2013
Keywords: roche, mabthera, improves, survival, nhl, months, new
Article | 20 December 2004
New data on Swiss drug major Roche's pioneering monoclonal antibody therapy for non-Hodgkin's lymphoma, presented at the American Society of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 December 2004
21 May 2013
© 2013 thepharmaletter.com